Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir for Peripheral CMV Retinitis
NCT00000799Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cidofovir in cytomegalovirus retinitis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
cidofovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000799.